Literature DB >> 12150992

p53: good cop/bad cop.

Norman E Sharpless1, Ronald A DePinho.   

Abstract

Activation of the p53 transcription factor in response to a variety of cellular stresses, including DNA damage and oncogene activation, initiates a program of gene expression that blocks the proliferative expansion of damaged cells. While the beneficial impact of the anticancer function of p53 is well established, several recent papers suggest that p53 activation may in some circumstances act in a manner detrimental to the long-term homeostasis of the organism. Here, we discuss the significant participation of p53 in three non-mutually exclusive theories of human aging involving DNA damage, telomere shortening, and oxidative stress. These "good cop/bad cop" functions of p53 appear to place it at the nexus of two opposing forces, cancer and aging. By extension, this relationship implies that therapies aimed to reduce cancer and postpone aging, and thereby increase longevity, will necessarily work either upstream or downstream, but not on the level of, p53.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12150992     DOI: 10.1016/s0092-8674(02)00818-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  77 in total

Review 1.  Nitric oxide-GAPDH-Siah: a novel cell death cascade.

Authors:  Makoto R Hara; Solomon H Snyder
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

2.  Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.

Authors:  Liu Cao; Wenmei Li; Sangsoo Kim; Steven G Brodie; Chu-Xia Deng
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

3.  Transcriptional response of lymphoblastoid cells to ionizing radiation.

Authors:  Kuang-Yu Jen; Vivian G Cheung
Journal:  Genome Res       Date:  2003-08-12       Impact factor: 9.043

4.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion.

Authors:  Utpal K Mukhopadhyay; Patrick Mooney; Lilly Jia; Robert Eves; Leda Raptis; Alan S Mak
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

Review 6.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

7.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

8.  PACT is a negative regulator of p53 and essential for cell growth and embryonic development.

Authors:  Li Li; Binwei Deng; Guichun Xing; Yan Teng; Chunyan Tian; Xuan Cheng; Xiushan Yin; Juntao Yang; Xue Gao; Yunping Zhu; Qihong Sun; Lingqiang Zhang; Xiao Yang; Fuchu He
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

9.  Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage.

Authors:  Xin Cai; Xuan Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

10.  p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1.

Authors:  Han You; YingJu Jang; Annick Itie You-Ten; Hitoshi Okada; Jennifer Liepa; Andrew Wakeham; Kathrin Zaugg; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.